trending Market Intelligence /marketintelligence/en/news-insights/trending/rR2wLrf8RhQNwrjT4LZ0pg2 content esgSubNav
In This List

Galena Biopharma, Cardinal Health settle product swap disputes

Blog

Insight Weekly: Bank boards lag on gender parity; future of office in doubt; US LNG exports leap

Blog

Insight Weekly: Job growth faces hurdles; shale firms sit on cash pile; Africa's lithium future

Blog

Insight Weekly: Loan growth picks up; US-China PE deals fall; France faces winter energy crunch

Blog

Perspectives from China: Chinese M&A in 2022


Galena Biopharma, Cardinal Health settle product swap disputes

Galena Biopharma Inc. agreed to settle all of its outstanding disputes with Cardinal Health Inc. over a product swap agreement.

Under the deal, Galena Biopharma will pay $500,000 to Cardinal Health. In turn, Cardinal Health will destroy all of the Zuplenz product returned due to the product swap. The related product swap agreement was also terminated as of the settlement date.

The companies entered into the agreement Sept. 25.